Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2019 1
2020 1
2022 1
2023 2
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

6 results

Results by year

Filters applied: . Clear all
Page 1
Hybrid and SARS-CoV-2-vaccine immunity in kidney transplant recipients.
Kared H, Alirezaylavasani A, Lund KP, Chopra A, Tietze L, de Matos Kasahara T, Goll GL, Grødeland G, Kaarbø M, Reisæter AV, Hovd M, Heldal K, Vaage JT, Lund-Johansen F, Midtvedt K, Åsberg A, Munthe LA. Kared H, et al. Among authors: alirezaylavasani a. EBioMedicine. 2023 Nov;97:104833. doi: 10.1016/j.ebiom.2023.104833. Epub 2023 Oct 14. EBioMedicine. 2023. PMID: 37844534 Free PMC article.
Immune responses in Omicron SARS-CoV-2 breakthrough infection in vaccinated adults.
Kared H, Wolf AS, Alirezaylavasani A, Ravussin A, Solum G, Tran TT, Lund-Johansen F, Vaage JT, Nissen-Meyer LS, Nygaard UC, Hungnes O, Robertson AH, Næss LM, Trogstad L, Magnus P, Munthe LA, Mjaaland S. Kared H, et al. Among authors: alirezaylavasani a. Nat Commun. 2022 Jul 18;13(1):4165. doi: 10.1038/s41467-022-31888-y. Nat Commun. 2022. PMID: 35851055 Free PMC article.
Generation of a Mouse Model Lacking the Non-Homologous End-Joining Factor Mri/Cyren.
Castañeda-Zegarra S, Huse C, Røsand Ø, Sarno A, Xing M, Gago-Fuentes R, Zhang Q, Alirezaylavasani A, Werner J, Ji P, Liabakk NB, Wang W, Bjørås M, Oksenych V. Castañeda-Zegarra S, et al. Among authors: alirezaylavasani a. Biomolecules. 2019 Nov 28;9(12):798. doi: 10.3390/biom9120798. Biomolecules. 2019. PMID: 31795137 Free PMC article.
Dynamics of SARS-CoV-2 immunity after vaccination and breakthrough infection in rituximab-treated rheumatoid arthritis patients: a prospective cohort study.
Kared H, Jyssum I, Alirezaylavasani A, Egner IM, The Tran T, Tietze L, Lund KP, Tveter AT, Provan SA, Ørbo H, Haavardsholm EA, Vaage JT, Jørgensen K, Syversen SW, Lund-Johansen F, Goll GL, Munthe LA. Kared H, et al. Among authors: alirezaylavasani a. Front Immunol. 2024 Feb 22;15:1296273. doi: 10.3389/fimmu.2024.1296273. eCollection 2024. Front Immunol. 2024. PMID: 38455062 Free PMC article.
People who use drugs show no increase in pre-existing T-cell cross-reactivity toward SARS-CoV-2 but develop a normal polyfunctional T-cell response after standard mRNA vaccination.
Gainullin M, Federico L, Røkke Osen J, Chaban V, Kared H, Alirezaylavasani A, Lund-Johansen F, Wildendahl G, Jacobsen JA, Sarwar Anjum H, Stratford R, Tennøe S, Malone B, Clancy T, Vaage JT, Henriksen K, Wüsthoff L, Munthe LA. Gainullin M, et al. Among authors: alirezaylavasani a. Front Immunol. 2024 Jan 17;14:1235210. doi: 10.3389/fimmu.2023.1235210. eCollection 2023. Front Immunol. 2024. PMID: 38299149 Free PMC article.